J&J partners with BARDA to fund COVID-19 vaccine research

J&J partners with BARDA to fund COVID-19 vaccine research

Johnson & Johnson has partnered with the Biomedical Advanced Research and Development Authority of the US Department of Health and Human Services to fund over $1 billion in COVID-19 vaccine and antiviral treatment R&D. The company has set a goal of providing a global supply of more than one billion doses of the vaccine, which it expects to have in clinical trials by September 2020 at the latest.

Chris
Chris
William
William 1 months

Good on them if its its true. Dr. Salk and sabine donated there polio vaccines. For the benefit of mankind. A very very very rare thing now a days.

Flitch
Flitch 1 months

As long as it doesn't have aspestos in it like some other products, then it could be a good thing. Johnson and Johnson don't have the best reputations.

No Signal
No Signal 1 months

They found a way of getting rid of all those cancer causing chemicals that they can no longer hide in baby powder.

Leo Miggel
Leo Miggel 1 months

Knowing J&J the vaccine will have cyanide as the main component

Top in Business
Get the App